Latin America Pharmaceutical Products CMO Market
- 2026 年市場規模
- USD 25.5 Bn
- 2033 年預估規模
- USD 38.46 Bn
- 年複合成長率 CAGR
- 6.95%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Latin America Pharmaceutical Products CMO Market, By Service Type (Contract Manufacturing Services (CMO) {Active Pharmaceutical Ingredient (API) Manufacturing, (Small Molecule APIs, Biologic APIs), Finished Dosage Form (FDF) Manufacturing (Solid Dosage Forms, Injectable Dosage Forms, Semi-solid Dosage Forms, Liquid Dosage Forms), Packaging Services (Primary Packaging, Secondary Packaging), Fill-Finish Services} and Contract Research Services (CRO), (Drug Discovery Services (Target Identification, and Lead Optimization), Preclinical Research (In Vitro Studies, and In Vivo Studies), Clinical Research (Phase I, Phase II, Phase III, Phase IV), Regulatory Affairs Services, Pharmacovigilance Services, Medical Writing Services)), By Product Type (Small Molecule Drugs, Biologics (Monoclonal Antibodies, Recombinant Proteins, Vaccines, Cell & Gene Therapies), and Biosimilars), By Therapeutic Area (Oncology, Infectious Diseases, Cardiovascular Diseases, Neurology, Metabolic Disorders, Respiratory Diseases, Immunology, Rare Diseases, Others), By Geography (Latin America)
報告摘要
Pharmaceutical products CMO provide wide range of manufacturing services, which include contract packaging, quality testing, and development service to pharmaceutical and biotechnology industries. Contract manufacturing organizations offer services from development of biologics to commercial scale production.
Market Dynamics
The Latin America pharmaceutical products CMO market is expected to witness significant growth during the forecast period, owing to the increasing expansion of international pharmaceutical companies in Latin America. For instance, in April 2020, the U.S. pharmaceutical company and French corporation Gennisium Pharma entered into the exclusive agreement under which m8 Pharmaceuticals has the exclusive rights to register and commercialize a more suitable formulation of an already existing orphan drug for apnea in Mexico and Brazil. Moreover, additional pipeline products for the treatment of conditions prevalent in premature newborn patients are also included in this partnership.
Low healthcare expenditure is expected to hinder growth of Latin America pharmaceutical products CMO market. For instance, according to the survey by Brazil’s Federal Council of Medicine in 2018, per capita public spending on health care in Brazil did not increase above the country’s official inflation, which rose by 80% from 2008 to 2017.
Key features of the study
• This report provides in-depth analysis of the Latin America pharmaceutical products CMO market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Latin America pharmaceutical products CMO market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include BASF SE, Bayer AG, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Novartis AG, Pfizer, Inc., Pisa Farmacéutica, Fresenius SE & Co. KGaA, Takeda Pharmaceutical Company Limited, Ferring Pharmaceuticals, Inc., and Landsteiner Scientific
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The Latin America pharmaceutical products CMO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Latin America pharmaceutical products CMO market
Market Segmentation
• By Service Type (Revenue, USD Bn, 2021-2033)
o Contract Manufacturing Services (CMO)
Active Pharmaceutical Ingredient (API) Manufacturing
o Small Molecule APIs
o Biologic APIs
Finished Dosage Form (FDF) Manufacturing
o Solid Dosage Forms
o Injectable Dosage Forms
o Semi-solid Dosage Forms
o Liquid Dosage Forms
Packaging Services
o Primary Packaging
o Secondary Packaging
Fill-Finish Services
o Contract Research Services (CRO)
Drug Discovery Services
o Target Identification
o Lead Optimization
Preclinical Research
o In Vitro Studies
o In Vivo Studies
Clinical Research
o Phase I
o Phase II
o Phase III
o Phase IV
Regulatory Affairs Services
Pharmacovigilance Services
Medical Writing Services
• By Product Type (Revenue, USD Bn, 2021-2033)
o Small Molecule Drugs
o Biologics
Monoclonal Antibodies
Recombinant Proteins
Vaccines
Cell & Gene Therapies
o Biosimilars
• By Therapeutic Area
o Oncology
o Infectious Diseases
o Cardiovascular Diseases
o Neurology
o Metabolic Disorders
o Respiratory Diseases
o Immunology
o Rare Diseases
o Others
• By End User
o Pharmaceutical Companies
o Biotechnology Companies
o Generic Drug Manufacturers
o Academic & Research Institutes
o Government Organizations
• By Region (Revenue, USD Bn, 2021-2033)
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
• Key Players
o BASF SE
o Bayer AG
o Boehringer Ingelheim GmbH
o Hoffmann-La Roche Ltd.
o Merck & Co., Inc.
o Novartis AG
o Pfizer, Inc.
o Pisa Farmaceutica
o Fresenius SE & Co. KGaA
o Takeda Pharmaceutical Company Limited
o Ferring Pharmaceuticals, Inc.
o Landsteiner Scientific
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Service Type
Market Snapshot, By Product Type
Market Snapshot, By Therapeutic Area
Market Snapshot, By End User
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Product Approval
o Collaboration/Merge/Acquisition
o Regulatory Landscape
o PEST Analysis
o Porter’s Five Forces Analysis
o Epidemiology
o Robust Pipeline Analysis
4. Latin America Pharmaceutical Products CMO Market, By Service Type, 2021 – 2033, (USD Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022– 2033
Segment Trends
o Contract Manufacturing Services (CMO)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Active Pharmaceutical Ingredient (API) Manufacturing
Small Molecule APIs
Biologic APIs
o Finished Dosage Form (FDF) Manufacturing
Solid Dosage Forms
Injectable Dosage Forms
Semi-solid Dosage Forms
Liquid Dosage Forms
o Packaging Services
Primary Packaging
Secondary Packaging
o Fill-Finish Services
o Contract Research Services (CRO)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Drug Discovery Services
Target Identification
Lead Optimization
o Preclinical Research
In Vitro Studies
In Vivo Studies
o Clinical Research
Phase I
Phase II
Phase III
Phase IV
o Regulatory Affairs Services
o Pharmacovigilance Services
o Medical Writing Services
5. Latin America Pharmaceutical Products CMO Market, By Product Type, 2021 – 2033, (USD Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022– 2033
Segment Trends
o Small Molecule Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Biologics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Monoclonal Antibodies
o Recombinant Proteins
o Vaccines
o Cell & Gene Therapies
o Biosimilars
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
6. Latin America Pharmaceutical Products CMO Market, By Therapeutic Area, 2021 – 2033, (USD Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022– 2033
Segment Trends
o Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Infectious Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Cardiovascular Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Neurology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Metabolic Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Respiratory Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Immunology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Rare Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
7. Latin America Pharmaceutical Products CMO Market, By End User, 2021 – 2033, (USD Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022– 2033
Segment Trends
o Pharmaceutical Companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Biotechnology Companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Generic Drug Manufacturers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Academic & Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Government Organizations
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
8. Latin America Pharmaceutical Products CMO Market, By Country, 2021 – 2033, (USD Billion)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022–2033
Regional Trends
o Brazil
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
o Mexico
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
o Argentina
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
o Rest Of Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
9. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profile
BASF SE
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Bayer AG
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Boehringer Ingelheim GmbH
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Hoffmann-La Roche Ltd.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Merck & Co., Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Novartis AG
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Pfizer Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Pisa Farmaceutica
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Fresenius SE & Co. KGaA
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Takeda Pharmaceutical Company Limited
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Ferring Pharmaceuticals, Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Landsteiner Scientific
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
o Analyst Views
10. Section
o References
o Research Methodology
o About Us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們